EYPT - EyePoint commences $175M stock offering to advance wet AMD therapy into late-stage
2023-12-04 16:26:58 ET
More on EyePoint Pharmaceuticals
- Shorting EyePoint Pharmaceuticals Ahead Of Davio-2 Wet-AMD Data: Potential 78% Gain
- Countdown To Clarity: EyePoint's December Data Delivery
- EyePoint Pharmaceuticals, Inc. (EYPT) Q3 2023 Earnings Conference Call Transcript
- Biggest stock movers today: Spotify, Uber Technologies, crypto-related stocks and more
- Seeking Alpha's Quant Rating on EyePoint Pharmaceuticals
For further details see:
EyePoint commences $175M stock offering to advance wet AMD therapy into late-stage